Search

Author/Creator Roth, Arnaud D.

1. Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial. (August 2018)

Authors:
Tejpar, Sabine; Yan, Pu; Piessevaux, Hubert; Dietrich, Daniel; Brauchli, Peter; Klingbiel, Dirk; Fiocca, Roberto; Delorenzi, Mauro; Bosman, Fred; Roth, Arnaud D.
Journal:
European journal of cancer
Issue:
Volume 99(2018)
Page Start:
66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study. (August 2018)

Authors:
Stocker, Gertraud; Hacker, Ulrich T.; Fiteni, Frédéric; John Mahachie, Jestinah; Roth, Arnaud D.; Van Cutsem, Eric; Peeters, Marc; Lordick, Florian; Mauer, Murielle
Journal:
European journal of cancer
Issue:
Volume 99(2018)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07). Issue 7 (9th January 2018)

Authors:
Montemurro, Michael; Cioffi, Angela; Dômont, Julien; Rutkowski, Piotr; Roth, Arnaud D.; von Moos, Roger; Inauen, Roman; Toulmonde, Maud; Burkhard, Roger O.; Knuesli, Claudio; Bauer, Sebastian; Cassier, Philippe; Schwarb, Heike; Le Cesne, Axel; Koeberle, Dieter; Bärtschi, Daniela; Dietrich, Daniel...
Journal:
Cancer
Issue:
Volume 124:Issue 7(2018)
Page Start:
1449
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search